申请人:Cho Aesop
公开号:US20110070194A1
公开(公告)日:2011-03-24
Provided are pyrrolo[1,2-f][1,2,4]triazinyl, imidazo[1,5-f][1,2,4]triazinyl, imidazo[1,2-f][1,2,4]triazinyl, and [1,2,4]triazolo[4,3-f][1,2,4]triazinyl nucleosides, nucleoside phosphates and prodrugs thereof, wherein the 2′ position of the nucleoside sugar is substituted with halogen and carbon substitutents. The compounds, compositions, and methods provided are useful for the treatment of Flaviviridae virus infections, particularly hepatitis C infections caused by both wild type and mutant strains of HCV.
提供了吡咯并[1,2-f][1,2,4]三唑基,咪唑并[1,5-f][1,2,4]三唑基,咪唑并[1,2-f][1,2,4]三唑基,以及[1,2,4]三唑并[4,3-f][1,2,4]三唑基核苷,核苷酸磷酸酯和它们的前药,其中核苷糖的2'位置被卤素和碳取代基取代。提供的化合物、组合物和方法对于治疗黄病毒科病毒感染特别有效,尤其是治疗由HCV的野生型和突变株引起的丙型肝炎感染。